Exact Mass: 292.0146
Exact Mass Matches: 292.0146
Found 289 metabolites which its exact mass value is equals to given mass value 292.0146,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
1,8-DINITROPYRENE
D009676 - Noxae > D002273 - Carcinogens D009676 - Noxae > D009153 - Mutagens CONFIDENCE standard compound; INTERNAL_ID 35
Carboxyphosphamide
In contrast to previous adult studies on urinary metabolites, plasma carboxyphosphamide concentrations did not support the existence of polymorphic metabolism. Plasma concentrations of dechlorethylcyclophosphamide and carboxyphosphamide were correlated in individual patients, suggesting that the activity of both aldehyde dehydrogenase and cytochrome P450 enzyme(s) determine carboxyphosphamide production in vivo. (PMID: 7850793) Detoxification of cyclophosphamide is effected, in part, by hepatic class 1 aldehyde dehydrogenase (ALDH-1)-catalyzed oxidation of aldophosphamide, a pivotal aldehyde intermediate, to the nontoxic metabolite, carboxyphosphamide. (PMID: 9394035) A key finding was the detection of a metabolite, most likely carboxyphosphamide, that is formed only by cytosols from cells expressing either class 3 or class 1 ALDH. (PMID: 8662659) D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards
Carboxyifosfamide
Carboxyifosfamide is a metabolite of ifosfamide. Ifosfamide (also marketed as Mitoxana and Ifex) is a nitrogen mustard alkylating agent used in the treatment of cancer. It is sometimes abbreviated IFO. (Wikipedia) D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards
clofop
D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D009676 - Noxae > D000963 - Antimetabolites
1,3-DINITROPYRENE
D009676 - Noxae > D002273 - Carcinogens D009676 - Noxae > D009153 - Mutagens
5-phospho-alpha-D-ribose cyclic-1,2-phosphate
Chlorosesamone
Chlorosesamone is found in fats and oils. Chlorosesamone is a constituent of the roots of Sesamum indicum (sesame) Constituent of the roots of Sesamum indicum (sesame). Chlorosesamone is found in fats and oils.
Bis(4-isothiocyanatobutyl) disulfide
Bis(4-isothiocyanatobutyl) disulfide is found in brassicas. Bis(4-isothiocyanatobutyl) disulfide is a constituent of salad rocket (Eruca sativa) Constituent of salad rocket (Eruca sativa). Bis(4-isothiocyanatobutyl) disulfide is found in brassicas.
Cordeauxione
Cordeauxione is found in nuts. Cordeauxione is isolated from leaf hairs of Cordeauxia edulis (yehib Isolated from leaf hairs of Cordeauxia edulis (yehib). Cordeauxione is found in nuts.
Citreovirone
Citreovirone is a mycotoxin produced by the rice storage mould Penicillium citreo-viride. Mycotoxin production by the rice storage mould Penicillium citreo-viride.
2-Hydroxychlorpropamide
2-Hydroxychlorpropamide is a metabolite of Chlorpropamide. 2-hydroxychlorpropamide belongs to the family of Benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.
3-Hydroxychlorpropamide
3-Hydroxychlorpropamide is only found in individuals that have used or taken Chlorpropamide. 3-Hydroxychlorpropamide is a metabolite of Chlorpropamide. 3-hydroxychlorpropamide belongs to the family of Benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.
S-methylazathioprine
S-methylazathioprine is a metabolite of azathioprine. Azathioprine is a purine analogue immunosuppressive drug. It is used to prevent rejection following organ transplantation, and to treat a vast array of autoimmune diseases, including rheumatoid arthritis, pemphigus, inflammatory bowel disease, multiple sclerosis, autoimmune hepatitis, atopic dermatitis, myasthenia gravis, neuromyelitis optica or Devics disease, restrictive lung disease, and others. (Wikipedia)
4-Hydroperoxycyclophosphamide
(5R,6S)-6-[(1R)-1-Hydroxyethyl]-7-oxo-3-pyridin-3-yl-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
Brevifolincarboxylic acid
Brevifolincarboxylic acid belongs to isocoumarins and derivatives class of compounds. Those are polycyclic compounds containing an isochromane which bears a ketone at the carbon C1. Brevifolincarboxylic acid is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Brevifolincarboxylic acid can be found in pomegranate, which makes brevifolincarboxylic acid a potential biomarker for the consumption of this food product. Brevifolincarboxylic acid is extracted from Polygonum capitatum[1], has inhibitory effect on the aryl hydrocarbon receptor (AhR)[2]. Brevifolincarboxylic acid is an α-glucosidase inhibitor with an IC50 of 323.46 μM[3]. Brevifolincarboxylic acid is extracted from Polygonum capitatum[1], has inhibitory effect on the aryl hydrocarbon receptor (AhR)[2]. Brevifolincarboxylic acid is an α-glucosidase inhibitor with an IC50 of 323.46 μM[3].
Brevifolincarboxylic acid
Brevifolincarboxylic acid is a natural product found in Melaleuca leucadendra, Euphorbia maculata, and other organisms with data available. Brevifolincarboxylic acid is extracted from Polygonum capitatum[1], has inhibitory effect on the aryl hydrocarbon receptor (AhR)[2]. Brevifolincarboxylic acid is an α-glucosidase inhibitor with an IC50 of 323.46 μM[3]. Brevifolincarboxylic acid is extracted from Polygonum capitatum[1], has inhibitory effect on the aryl hydrocarbon receptor (AhR)[2]. Brevifolincarboxylic acid is an α-glucosidase inhibitor with an IC50 of 323.46 μM[3].
Brevifolincarboxylic
Brevifolincarboxylic acid is a natural product found in Melaleuca leucadendra, Euphorbia maculata, and other organisms with data available. Brevifolincarboxylic acid is extracted from Polygonum capitatum[1], has inhibitory effect on the aryl hydrocarbon receptor (AhR)[2]. Brevifolincarboxylic acid is an α-glucosidase inhibitor with an IC50 of 323.46 μM[3]. Brevifolincarboxylic acid is extracted from Polygonum capitatum[1], has inhibitory effect on the aryl hydrocarbon receptor (AhR)[2]. Brevifolincarboxylic acid is an α-glucosidase inhibitor with an IC50 of 323.46 μM[3].
N(4)-Acetylsulfadiazine
A sulfonamide that is benzenesulfonamide substituted by an acetylamino group at position 4 and a pyrimidin-2-yl group at the nitrogen atom. It is a metabolite of the drug sulfadiazine. D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
9H-Xanthen-9-one, 2-chloro-1,3,6-trihydroxy-8-methyl-
2-Oxo-3-(alpha,3,4-trihydroxyphenethyl)-2H-pyran-6-carboxylic acid
3-(1-Hydroxy-3-oxobutyl)-4-oxo-7-hydroxy-4H-1-benzopyran-5-carboxylic acid
N-[1-(4-aminophenyl)-1,3-dihydroxypropan-2-yl]-2,2-dichloroacetamide
1-Oxo-2-phenyl-pent-2-en-1,3,5-tricarbonsaeure|1-oxo-2-phenyl-pent-2-ene-1,3,5-tricarboxylic acid
2-Methyl-4-oxo-8,9-dihydroxy-3,4-dihydro-2H,5H-pyrano[3,2-c][1]benzopyran-10-carboxylic acid
1-Alcohol,Me ester-Aipha-Oxo-5-(1-propynyl)[2,2-bithiophene]-5-acetic acid
2,5,8-trihydroxy-6-methoxy-3-(2-oxopropyl)-1,4-naphthoquinone|6-Me ether-2,5,6,8-Tetrahydroxy-3-(2-oxopropyl)-1,4-naphthoquinone
2-acetoxy-4-[2,2]bithiophenyl-5-yl-but-3-yn-1-ol|5-(3-acetoxy-4-hydroxy-1-butynyl)-2,2-bithiophene|5-(4-Hydroxy-3-acetoxybutin-1-yl)-bithienyl-2,2
N4-Acetylsulfadiazine
D000890 - Anti-Infective Agents > D013424 - Sulfanilamides CONFIDENCE standard compound; EAWAG_UCHEM_ID 248 CONFIDENCE standard compound; INTERNAL_ID 2013
4-Chloro-N-[(2-hydroxypropyl)carbamoyl]benzenesulfonamide
NSC 652287
RITA is an inhibitor of p53-HDM-2 interaction, binds to p53dN, with a Kd of 1.5 nM, and also induces DNA-DNA cross-links.
2-ETHOXY-5-(3-METHYL-UREIDO)-BENZENESULFONYL CHLORIDE
2-(3-METHYL-4-NITRO-PHENYL)-THIAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
Butedronic acid
C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor
ethyl 8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate
3-CHLORO-3,5-DIMETHOXY-[1,1-BIPHENYL]-4-CARBOXYLIC ACID
5-Bromo-8-ethoxy-4-hydroxy-3-quinolinecarbonitrile
2-CHLORO-N-(5-CYCLOBUTYL-[1,3,4]THIADIAZOL-2-YL)-ACETAMIDE
5-bromo-3-((1-Methylpyrrolidin-2-yl)Methyl)-1H-indole
(7-CHLOROTHIAZOLO[5,4-D]PYRIMIDIN-2-YL)-(4-METHOXYPHENYL)AMINE
Methanone, (2,4-dichlorophenyl)[(2R,3S)-3-phenyloxiranyl]-
Dichloro(N,N,N,N-tetramethylethylenediamine)palladium(II)
O,O-diethyl O-[4-(methylthio)phenyl] thiophosphate
2-(2-Amino-phenylsulfanyl)-N-(2-chloro-phenyl)-acetamide
2-Bromo-6-(3-piperidinyloxy)pyridine hydrochloride
2-Bromo-6-(4-piperidinyloxy)pyridine hydrochloride
4-Hydroperoxycyclophosphamide
A phosphorodiamide that is the active metabolite of the nitrogen mustard cyclophosphamide. It has potent antineoplastic and immunosuppressive properties. D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards
6-CHLORO-1-(PHENYLSULFONYL)-1H-PYRROLO[2,3-B]PYRIDINE
3-THIOPHENECARBOXYLIC ACID-5-METHYL-2-{2-(NITROPHENYL)AMINO}METHYL ESTER
(R)-5-Bromo-3-((1-methylpyrrolidin-2-yl)methyl)-1H-indole
4-bromo-2-cyclobutyloxy-1-(difluoromethoxy)benzene
2H-1,3,2-Oxazaphosphorin-2-amine,N,3-bis(2-chloroethyl)tetrahydro-4-hydroperoxy-, 2-oxide
ETHYL 5-CHLORO-2-METHYL-4-SULFAMOYLPHENYLCARBAMATE
(2,3,4,5,6-pentafluorophenyl) 2-methylpyrazole-3-carboxylate
1-ETHYL-2-METHYL-5-[(TRIFLUOROMETHYL)SULFONYL]-1H-BENZIMIDAZOLE
2-(4-AMINO-3-CHLORO-PHENYL)-4-CHLORO-3H-BENZOIMIDAZOL-5-YLAMINE
ETHYL 5-CYANAMIDE-4-(2-FLUOROPHENYL)-4,5-DIHYDRO-1,3,4-THIADIAZOLE-2-CARBOXYLATE
alpha-N-Dichloroacetyl-P-aminophenylserinol
dimethyl 3-(4-chlorophenoxy)-2-oxopropylphosphonate
1H-Pyrrolo[2,3-b]pyridine, 4-chloro-1-(phenylsulfonyl)-
Dimethyl [3-(3-chlorophenoxy)-2-oxopropyl]phosphonate
3-AMINO-5-(3-NITRO-PHENYL)-THIOPHENE-2-CARBOXYLIC ACID ETHYL ESTER
N-(2-CHLORO-3-PHENYLIMINO-1-PROPEN-1-YL)-ANILINE HYDROCHLORIDE
Ethyl 5-(4-chloro-1H-pyrrolo[2,3-b]pyridin-5-yl)-1,2,4-oxadiazole -3-carboxylate
3-[[2-(trifluoromethyl)phenyl]carbamothioylamino]propanoic acid
dimethyl 5-chlorosulfonylbenzene-1,3-dicarboxylate
2-(acetylamino)-5-(aminosulphonyl)-4-chlorobenzoic acid
(4-Bromo-thiazol-2-yl)-Methyl-carbamic acid tert-butyl ester
Ethyl 3-amino-5-(4-nitrophenyl)thiophene-2-carboxylate
Gastric Inhibitory Polypeptide (porcine) trifluoroacetate salt
ethyl 6-chloro-2-(trifluoroMethyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylate
TRIETHYLSILYL 2,2-DIFLUORO-2-(FLUOROSULFONYL)ACETATE
Ethyl 2-(5-bromo-2-methylphenyl)-2,2-difluoroacetate
(4,8-dioxothieno[3,2-f][1]benzothiol-2-yl)methyl acetate
N-((4-Aminophenyl)sulfonyl)-N-(pyrimidin-2-yl)acetamide
4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-[(1R)-1-hydroxyethyl]-7-oxo-3-(3-pyridinyl)-, (5R,6S)-
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
4-Sulfanilamidobenzoic acid
D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
(3,5-Dichloro-2,4,6-trihydroxyphenyl)hexan-1-one
An aromatic ketone that is phloroglucinol in which two of the hydrogens attached to the benzene ring have been replaced by chlorines while the third has been replaced by a hexanoyl group. It is the immediate biosynthetic precursor for differentiation-inducing factor 1 (DIF-1). DIF-1 is released by developing Dictyostelium amoebae, inducing them to differentiate into stalk cells.
2-chloro-1-[5-(furan-2-yl)-3-(5-methylfuran-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]ethan-1-one
2-Chloro-3,6,8-trihydroxy-1-methyl-9H-xanthen-9-one
1-(3,5-Dichloro-2,6-dihydroxy-4-methoxyphenyl)pentan-1-one
A differentiation-inducing factor that is pentaphenone bearing two chloro substituents at positions 3 and 5, two hydroxy substituents at positions 2 and 6 as well as a single methoxy substituent at position 4. A secreted, chlorinated molecule that controls cell fate during development of Dictyostelium cells.
2-chloro-1-[2,5-dimethyl-1-(3-nitrophenyl)-1H-pyrrol-3-yl]ethan-1-one
5-(2-thienyl)-4-{[(E)-2-thienylmethylidene]amino}-4H-1,2,4-triazole-3-thiol
2-[7-(Carboxymethoxy)-4-methyl-2-oxo-1-benzopyran-3-yl]acetic acid
Perfosfamide
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
Pergamid (TN)
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards
3,5,8-Trihydroxy-2-(2-oxopropyl)-7-methoxynaphthalene-1,4-dione
RITA (NSC 652287)
RITA is an inhibitor of p53-HDM-2 interaction, binds to p53dN, with a Kd of 1.5 nM, and also induces DNA-DNA cross-links.
4-(1-Imidazolyl)-3,5-dinitrobenzoic acid methyl ester
1-(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)pyrimidin-2(1H)-one
2-[(4-Chlorophenyl)methylthio]-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-4-one
6-Chloro-2-[N-(2-nitro-benzylidene)-hydrazino]-pyrimidin-4-ylamine
N-(5-chloro-2-methoxyphenyl)-5-cyclopropyl-3-isoxazolecarboxamide
1-(4-Chlorophenyl)sulfonyl-3-(3-hydroxypropyl)urea
Methyl 2-hydroxy-3-(4-hydroxy-3-sulooxyphenyl)propanoate
2-Hydroxy-3-(4-methoxy-3-sulooxyphenyl)propanoic acid
3-(3-Hydroxy-5-methoxy-4-sulooxyphenyl)propanoic acid
2-Hydroxy-3-(3-methoxy-4-sulooxyphenyl)propanoic acid
Methyl 3-(3,4-dihydroxyphenyl)-2-sulooxypropanoate
2-(2-Hydroxy-4-methoxy-3-sulooxyphenyl)propanoic acid
Carboxyphosphamide
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards
Carboxyifosfamide
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards
Cysteinylglycine (TFA)
Cysteinylglycine TFA is an endogenous metabolite and used in disease diagnosis[1].
KRAS inhibitor-9
KRAS inhibitor-9, a potent KRAS inhibitor (Kd=92 μM), blocks the formation of GTP-KRAS and downstream activation of KRAS. KRAS inhibitor-9 binds to KRAS G12D, KRAS G12C and KRAS Q61H protein with a moderate binding affinity. KRAS inhibitor-9 causes G2/M cell cycle arrest and induces apoptosis. KRAS inhibitor-9 selectively inhibits the proliferation of NSCLC cells with KRAS mutation but not normal lung cells[1].
(5r)-6,7,8-trihydroxy-1,3-dioxo-2h,5h-cyclopenta[c]isochromene-5-carboxylic acid
2,5,8-trihydroxy-6-methoxy-3-(2-oxopropyl)naphthalene-1,4-dione
6-acetyl-2,5,8-trihydroxy-3-methoxy-7-methylnaphthalene-1,4-dione
6-acetyl-3,5,8-trihydroxy-2-methoxy-7-methylnaphthalene-1,4-dione
2-chloro-5,8-dihydroxy-3-prenyl-1,4-naphthoquinone
{"Ingredient_id": "HBIN005456","Ingredient_name": "2-chloro-5,8-dihydroxy-3-prenyl-1,4-naphthoquinone","Alias": "NA","Ingredient_formula": "C15H13ClO4","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8672","PubChem_id": "NA","DrugBank_id": "NA"}
.alpha.-T COOH deriv.
{"Ingredient_id": "HBIN015692","Ingredient_name": ".alpha.-T COOH deriv.","Alias": "5-[5-(2-thienyl)-2-thienyl]-2-thiophenecarboxylic acid; (2,2':5',2''-Terthiophene)-5-carboxylic acid; 2,2':5',2\"-Terthiophene-5-carboxylic acid; 5-(5-thiophen-2-ylthiophen-2-yl)thiophene-2-carboxylic acid; AIDS-005102; AIDS005102; 5-[5-(2-thienyl)-2-thienyl]-2-thenoic acid; 87145-85-5; 5-[5-(2-thienyl)-2-thienyl]thiophene-2-carboxylic acid","Ingredient_formula": "C13H8O2S3","Ingredient_Smile": "C1=CSC(=C1)C2=CC=C(S2)C3=CC=C(S3)C(=O)O","Ingredient_weight": "292.4","OB_score": "24.5199737","CAS_id": "87145-85-5","SymMap_id": "SMIT05457","TCMID_id": "NA","TCMSP_id": "MOL003375","TCM_ID_id": "NA","PubChem_id": "159047","DrugBank_id": "NA"}
